Can you provide more details on the different BRCA1/2 and other genetic tests that will be performed? What is the...
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Question asked:
Can you provide more details on the different BRCA1/2 and other genetic tests that will be performed? What is the timeline for getting the results, and how will this information be used to guide my treatment plan?
I notice you're asking about BRCA1/2 testing, but I see from your history that you have lymphoma. Let me clarify - BRCA1/2 testing is typically associated with breast and ovarian cancer risk. For lymphoma patients, different genetic tests are typically recommended.
According to the National Comprehensive Cancer Network (NCCN) Guidelines for Non-Hodgkin Lymphoma, the key genetic and molecular tests for lymphoma typically include:
- Immunophenotyping/Flow cytometry
- Chromosome analysis
- FISH (Fluorescence In Situ Hybridization) testing
- Molecular testing for specific genetic markers
The Leukemia & Lymphoma Society (LLS) indicates that these test results usually take:
- Flow cytometry: 2-3 days
- FISH testing: 3-5 days
- Molecular testing: 7-14 days
According to NCCN Guidelines, these test results help determine:
- The specific subtype of lymphoma
- Prognosis
- Most effective treatment options
- Potential eligibility for targeted therapies or clinical trials
I recommend discussing with your healthcare team which specific genetic tests they're planning for your case, as the exact tests can vary based on your lymphoma subtype and other clinical factors.
Would you like me to provide more specific information about any of these particular tests? Also, please let me know if I misunderstood your situation regarding BRCA testing.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Diffuse Large B-Cell Lymphoma (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for Lymphoma patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: